Europe IVD Devices Contract Manufacturing Market Analysis and Forecast by Size, Share, Growth, Trends 2034

The Europe IVD Devices Contract Manufacturing Market size is expected to reach US$ 18,230.1 Million by 2034 from US$ 6,605.8 Million in 2025. The market is estimated to record a CAGR of 12.0% from 2026 to 2034.

Executive Summary and Europe IVD Devices Contract Manufacturing Market Analysis:

The IVD devices contract manufacturing market in Europe is segmented into the UK, Germany, France, Italy, Spain, Rest of Europe. The market thrives on established healthcare systems and regulatory compliance, with a focus on diagnostics specialization. ~40% of CDMOs target diagnostics, driven by major players such as Philips and Roche, emphasizing IVD and medical imaging. Growth varies by country: the UK saw a 3.3% increase in IVD revenues, largely from glucose test strips, while Spain experienced 1.5% and France 0.8%. Trends include vertical integration and consolidation, with merger and acquisition activity robust in 2023, over half cross-border, targeting orthopedics and cardiovascular applications. For instance, the UK government plans 160 community diagnostic centers, accelerating demand for outsourced production. In Germany, laboratory diagnostics cost around US$15.05 billion annually, with 108,000 workers in medical labs representing 1.8% of the healthcare workforce. IVD expenditure averages 0.63% of total healthcare in EU-15 countries, but newer members show 5.8% growth. Contract manufacturers leverage precision engineering for assays and probes, supporting personalized medicine. Aging demographics drive demand for age-related diagnostics, with Europe holding a significant share due to advanced infrastructure. Partnerships, such as those in Italy for MeMed BV tests, enhance distribution. The region reinvests about 1 billion euros yearly in research and development, with 95% of the industry comprising SMEs. This fosters innovation in rapid tests and molecular diagnostics, improving accessibility and efficiency in healthcare delivery across diverse markets.

Europe IVD Devices Contract Manufacturing Market: Strategic Insights

Europe IVD Devices Contract Manufacturing Market Segmentation Analysis:

• By Service Type, the Europe IVD Devices Contract Manufacturing Market is segmented into Full-device Manufacturing, Sub-assembly and Components, and Materials-specific Services. The Full-device Manufacturing segment dominated the market in 2025.
• By Device Type, the Europe IVD Devices Contract Manufacturing Market is segmented into IVD Consumables and IVD Equipment. The IVD Consumables segment dominated the market in 2025.

Europe IVD Devices Contract Manufacturing Market Players Density: Understanding Its Impact on Business Dynamics

The Europe IVD Devices Contract Manufacturing Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Europe IVD Devices Contract Manufacturing Market Outlook

The pursuit of cost savings and operational efficiencies, as OEMs outsource non-core manufacturing activities to specialized contract firms, allows them to allocate resources toward research and development while minimizing capital expenditures. Contract manufacturing provides advantages such as lower labor and facility costs, streamlined logistics through integrated processes, and access to advanced equipment without upfront investment. For emerging and smaller IVD companies, this avoids the high costs of building in-house capabilities, enabling flexible scaling from small batches to high-volume production. Time efficiencies are also substantial, with reduced lead times and simplified supply chains enhancing overall competitiveness. For instance, the widespread outsourcing during the COVID-19 pandemic, where IVD firms rapidly scaled production of over 500 diagnostic tests by partnering with contract manufacturers, achieved faster market entry and cost reductions amid supply disruptions. This approach also improves resilience by diversifying production locations and adopting just-in-case inventory strategies post-pandemic. Outsourcing optimizes audit and compliance processes through established expertise, reducing manual efforts and errors via standardized automation. Broader trends show IVD companies reporting substantial savings and improved error-free scaling when leveraging contract partners for reagent handling, assembly, and packaging. These efficiencies enable firms to navigate regulatory complexities, focus on core innovations, and maintain agility in a competitive, high-demand diagnostics landscape.

Europe IVD Devices Contract Manufacturing Market Country Insights

By country, the Europe IVD Devices Contract Manufacturing Market is segmented into Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. Germany held the largest share in 2025.

The IVD devices contract manufacturing market in Germany operates under the Federal Institute for Drugs and Medical Devices (BfArM) and aligns with EU IVDR, mandating ISO 13485 certification for quality and risk management. This supports precision engineering and export-oriented production. Prominent examples include STRATEC, providing modular automation and contract manufacturing for IVD analyzers and reagents. Merck KGaA offers comprehensive CDMO services for IVD reagents, antibodies, and kits, leveraging GMP facilities. Röchling specializes in plastic components and assembly for IVD devices, focusing on high-precision molding. Jena Bioscience provides custom nucleotide and assay manufacturing for molecular diagnostics.

As per the National Health Institute, 840 microbiological specialists and 1,200 laboratory medicine experts, comprising 0.7% of specialized physicians, with 108,000 employed in medical labs (1.8% of the healthcare workforce). Annual lab diagnostics volume exceeds 500 million tests, driving CMO demand. Over 80 medtech CDMOs operate in Germany, with 60% headquartered there, emphasizing cardiovascular and IVD focus. Additionally, trends involve advanced manufacturing for sophisticated instruments, with nearshoring reducing supply chain risks. Emphasis on AI and multiplex PCR grows amid aging populations, with outsourcing optimizing operations and identifying inefficiencies. Regulatory compliance under IVDR boosts specialized CMOs.

Europe IVD Devices Contract Manufacturing Market Company Profiles

Some of the key players operating in the market include TE Connectivity Ltd, Jabil Inc, Nova Biomedical Corporation, Flex Ltd, Celestica Inc, Fujirebio Europe NV, Thermo Fisher Scientific Inc., Nemera, SMC Ltd, and HiArc

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Europe IVD Devices Contract Manufacturing Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise